Latest news
Loading news…
Qiagen
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Venlo, Limburg, The Netherlands Founded 1986 5001-10000 employees For Profit
QIAGEN provides technologies and products for preanalytical sample preparation and linked molecular assay solutions.
Qiagen was acquired by ATCC in 2022.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
32
Investments
10
6 exits
Monthly Visits
Available in Pro Contacts
2,771
Ticker
QGEN
NYSE - New York Stock Exchange
Patents
590
380 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- QGEN
- Exchange
- NYSE - New York Stock Exchange
- IPO date
- Jul 5, 1996
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 163
- Mobile apps
- 8
- Active products
- 51
- Patents granted
- 590
- Trademarks
- 380
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $45.36M
Investor Activity
- Investments
- 10
- Lead investments
- 4
- Portfolio orgs
- 9
- Diversity investments
- 1
- Exits
- 6
- Exits via IPO
- 1
Company Info
- Founded
- 1986
- Employees
- 5001-10000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 2
- Sub-organizations
- 9
- News articles
- 1,097
- Events
- 2
- HQ
- Venlo, Limburg, The Netherlands
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Jul 5, 1996
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 2.1
- Trend (30d)
- -0.8
- Trend (90d)
- 2.6
- Last leadership hire
- Jun 26, 2025
- Last layoff mention
- Jul 18, 2024
Investments by Qiagen
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Qiagen
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Qiagen
VP Biomedical Informatics & Ingenuity
Chief Executive Officer
Sr. Director, Assay Development
Vice President, Business Development, Companion Diagnostics
CEO
Associate Director HID GEDmatch Product Manager
2,771
professional contacts at Qiagen
Contact execs at Qiagen →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Qiagen
Loading news…
FAQs about Qiagen
People who checked this page also checked these
Sectors Qiagen invests & acquires in
Browse the full Acquirezy directory.